Altshuler Shaham’s Biogen BIIB Stock Holding History

Altshuler Shaham’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-91	Closed	-$25.2K	–	382
2022 Q4	$25.2K	Buy	+91	New	+$25.7K	﹤0.01%	341
2021 Q1	–	Sell	-1,694	Closed	-$415K	–	460
2020 Q4	$415K	Sell	1,694 -538	-24%	-$139K	0.01%	121
2020 Q3	$633K	Sell	2,232 -788	-26%	-$220K	0.01%	95
2020 Q2	$808K	Buy	3,020 +625	+26%	+$188K	0.02%	73
2020 Q1	$757K	Sell	2,395 -1,960	-45%	-$595K	0.04%	60
2019 Q4	$1.29M	Sell	4,355 -860	-16%	-$239K	0.04%	67
2019 Q3	$1.2M	Sell	5,215 -672	-11%	-$156K	0.05%	63
2019 Q2	$1.38M	Buy	5,887 +1,082	+23%	+$250K	0.06%	63
2019 Q1	$1.14M	Buy	+4,805	New	+$1.51M	0.05%	82
2018 Q2	–	Sell	-7,075	Closed	-$1.94M	–	216
2018 Q1	$1.94M	Buy	+7,075	New	+$2.2M	0.26%	55

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Altshuler Shaham's BIIB Position: Q1 2023 in Review

Altshuler Shaham sold out of Biogen (BIIB) in Q1 2023, closing a stake of 91 shares — an estimated $25.2K sold.

Altshuler Shaham first reported a position in BIIB in Q1 2018 and held it in 10 quarters. The position peaked at $1.94M in Q1 2018. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

Altshuler Shaham reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
Altshuler Shaham sold 91 Biogen shares in Q1 2023, an estimated $25.2K.
Altshuler Shaham first reported a position in Biogen in Q1 2018 and held it in 10 quarters.
Altshuler Shaham's Biogen position peaked at $1.94M in Q1 2018.
1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on Altshuler Shaham's 13F filing for Q1 2023, filed 9 May 2023.